109 related articles for article (PubMed ID: 22209964)
1. Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia.
Lee YT; Chen SC; Shyu LY; Lee MC; Wu TC; Tsao SM; Yang SF
Clin Chim Acta; 2012 Mar; 413(5-6):630-5. PubMed ID: 22209964
[TBL] [Abstract][Full Text] [Related]
2. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
[TBL] [Abstract][Full Text] [Related]
3. Plasma endothelial cell-specific molecule-1 (ESM-1) in management of community-acquired pneumonia.
Kao SJ; Chuang CY; Tang CH; Lin CH; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2014 Mar; 52(3):445-51. PubMed ID: 24108208
[TBL] [Abstract][Full Text] [Related]
4. Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia.
Chang JH; Hung WY; Bai KJ; Yang SF; Chien MH
Int J Med Sci; 2016; 13(9):673-9. PubMed ID: 27647996
[TBL] [Abstract][Full Text] [Related]
5. Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease.
Tsai HT; Wang PH; Tee YT; Lin LY; Hsieh YS; Yang SF
Fertil Steril; 2009 Feb; 91(2):549-55. PubMed ID: 18314113
[TBL] [Abstract][Full Text] [Related]
6. Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia.
Yong KK; Chang JH; Chien MH; Tsao SM; Yu MC; Bai KJ; Tsao TC; Yang SF
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840299
[TBL] [Abstract][Full Text] [Related]
7. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
Nishikawa H; Ozaki Y; Nakanishi T; Blomgren K; Tada T; Arakawa A; Suzumori K
Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
[TBL] [Abstract][Full Text] [Related]
8. The circulating level of MMP-9 and its ratio to TIMP-1 as a predictor of severity in patients with community-acquired pneumonia.
Chiang TY; Yu YL; Lin CW; Tsao SM; Yang SF; Yeh CB
Clin Chim Acta; 2013 Sep; 424():261-6. PubMed ID: 23792071
[TBL] [Abstract][Full Text] [Related]
9. Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.
Yeh YH; Chang JL; Hsiao PC; Tsao SM; Lin CH; Kao SJ; Chou MC; Yang SF; Chien MH
J Clin Lab Anal; 2013 Jul; 27(4):253-60. PubMed ID: 23852780
[TBL] [Abstract][Full Text] [Related]
10. Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls.
Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
J Alzheimers Dis; 2010; 22(4):1223-30. PubMed ID: 20930303
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma stromal-cell-derived factor-1 protein levels correlate with severity in patients with community-acquired pneumonia.
Tsai PK; Hsieh MJ; Wang HL; Chou MC; Yang SF; Yeh CB
Dis Markers; 2014; 2014():829706. PubMed ID: 25371597
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of soluble intercellular adhesion molecule-1 as a biomarker for disease severity of patients with community-acquired pneumonia.
Chang PY; Tsao SM; Chang JH; Chien MH; Hung WY; Huang YW; Yang SF
Clin Chim Acta; 2016 Dec; 463():174-180. PubMed ID: 27983998
[TBL] [Abstract][Full Text] [Related]
13. Excessive matrix metalloproteinase-9 in the plasma of community-acquired pneumonia.
Yang SF; Chu SC; Chiang IC; Kuo WF; Chiou HL; Chou FP; Kuo WH; Hsieh YS
Clin Chim Acta; 2005 Feb; 352(1-2):209-15. PubMed ID: 15653116
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients.
Wang HL; Hsiao PC; Tsai HT; Yeh CB; Yang SF
Int J Mol Sci; 2013 Nov; 14(11):22817-25. PubMed ID: 24256818
[TBL] [Abstract][Full Text] [Related]
16. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
[TBL] [Abstract][Full Text] [Related]
17. Mortality prediction in community-acquired pneumonia requiring mechanical ventilation; values of pneumonia and intensive care unit severity scores.
Aydoğdu M; Ozyilmaz E; Aksoy H; Gürsel G; Ekim N
Tuberk Toraks; 2010; 58(1):25-34. PubMed ID: 20517726
[TBL] [Abstract][Full Text] [Related]
18. Endogenous carboxyhemoglobin concentrations in the assessment of severity in patients with community-acquired pneumonia.
Corbacioglu SK; Kilicaslan I; Bildik F; Guleryuz A; Bekgoz B; Ozel A; Keles A; Demircan A
Am J Emerg Med; 2013 Mar; 31(3):520-3. PubMed ID: 23219346
[TBL] [Abstract][Full Text] [Related]
19. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
Tumminello FM; Flandina C; Crescimanno M; Leto G
Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
[TBL] [Abstract][Full Text] [Related]
20. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hanschmann A; Marre R; Suttorp N; Welte T;
J Antimicrob Chemother; 2009 Jul; 64(1):159-62. PubMed ID: 19403654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
